Akers Biosciences Inc (AKR)

 

Latest News

Holding(s) in Company

RNS Number: 6354L Akers Biosciences, Inc. 20 July 2017 July 20, 2017 Akers Biosciences, Inc. Holdings in Company Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces that it has become aware that Hudson Bay Master Fund, LTD has an interest in 632,080 common...

Board changes proposed at Akers Biosciences' AGM

Akers Biosciences has announced that a number of board changes would be proposed at its annual general meeting on 7 A...

Notice of AGM & Directorate Changes

RNS Number: 0430L Akers Biosciences, Inc. 14 July 2017 July 14, 2017 This announcement contains inside information Akers Biosciences, Inc. Notice of Annual General Meeting & Proposed Directorate Changes Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces th...

Form S-3 Registration Statement

RNS Number: 9601J Akers Biosciences, Inc. 03 July 2017 July 3, 2017 Akers Biosciences, Inc. Form S-3 Registration Statement Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces that its Form S-3 Registration Statement filed on April 19, 2017, as amended, in connectio...

All News

DateHeadlineSource
20-07-17Holding(s) in CompanyRNS
14-07-17Board changes proposed at Akers Biosciences' AGMStockMarketWire
14-07-17Notice of AGM & Directorate ChangesRNS
03-07-17Form S-3 Registration StatementRNS
09-06-17Issue of EquityRNS
16-05-17Akers Biosciences revenue down StockMarketWire
16-05-171st Quarter ResultsRNS
12-05-17Akers Biosciences schedules interimsStockMarketWire
12-05-17Notice of Q1 ResultsRNS
05-05-17Issue of EquityRNS
24-04-17Issue of EquityRNS
11-04-17Holding(s) in CompanyRNS
11-04-17Akers Bio revenues up 40%StockMarketWire
11-04-17Final ResultsRNS
10-04-17Notice of ResultsRNS
10-04-17Issue of EquityRNS
10-04-17Akers Bio marketing HIT rapid test in Puerto RicoStockMarketWire
10-04-17Heparin PF4 Rapid Test in Puerto RicoRNS
07-04-17Akers Bio warrants exercised StockMarketWire
06-04-17Issue of EquityRNS
04-04-17Issue of EquityRNS
31-03-17FTSE falls on miners, financials as Old Mutual suffersStockMarketWire
31-03-17Issue of EquityRNS
30-03-17Detailed Year-end Trading UpdateRNS
29-03-17Notice of ResultsRNS
28-03-17Initial Order for Rapid Cholesterol Self-testRNS
16-02-17Akers Bio granted US patent StockMarketWire
16-02-17US Patent for Akers Wellness Tests CartridgeRNS
01-02-17Akers Bio revenues up 66%StockMarketWire
01-02-17Trading UpdateRNS
13-01-17Akers Bio offering increased StockMarketWire
13-01-17Issue of EquityRNS
10-01-17Issue of EquityRNS
09-01-17Supplement to Form S-3 Registration StatementRNS
20-12-16Akers Bio resolutions passed at AGMStockMarketWire
19-12-16Result of AGMRNS
19-12-16Agreement with GNYHA for PIFA Heparin PF4 TestRNS
01-12-16US Distribution Agreement: Cholesterol Self-testRNS
28-11-16Akers Bio completes BreathScan DKA trial StockMarketWire
28-11-16Clinical Trial for BreathScan DKA CompletedRNS

RSS feeds

  • Editorial news feed for LSE:AKR Editorial
  • Regulatory news feed for LSE:AKR Regulatory